Related Experiment Video

Updated: May 27, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer

D Lin1, F Cui, Q Bu

  • 1Urology Department, The First Affiliated Hospital of Suzhou University, Suzhou, China.

The Journal of International Medical Research
|November 29, 2011
PubMed

Insights

Prostate cancer progression may be linked to lower levels of the tumor suppressor gene ARHI (Guanosine-5'-triphosphate (GTP)-binding RAS-like 3) and higher levels of microRNA 221 and 222. Further research is needed to confirm their biomarker potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Prostate cancer is a leading male malignancy with no established biomarkers for tumor invasion and progression.
  • Guanosine-5'-triphosphate (GTP)-binding RAS-like 3 (ARHI), a tumor suppressor gene, is downregulated in prostate cancer cell lines.
  • MicroRNA 221 and 222 negatively regulate ARHI expression.

Purpose of the Study:

  • To investigate the expression levels of ARHI, microRNA 221, and microRNA 222 in aggressive versus non-aggressive prostate cancer tissue.
  • To explore the potential of ARHI and microRNAs 221/222 as biomarkers for prostate cancer progression.

Main Methods:

  • Real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify gene and microRNA expression.
  • Tissue samples from 35 prostate cancer patients, categorized by Gleason grade (aggressive vs. non-aggressive), were analyzed.

Main Results:

  • ARHI mRNA levels were significantly lower in aggressive prostate cancer tissues compared to non-aggressive tissues.
  • MicroRNA 221 and 222 levels were significantly higher in aggressive prostate cancer tissues compared to non-aggressive tissues.

Conclusions:

  • The study identified an inverse correlation between ARHI expression and aggressive prostate cancer.
  • Elevated microRNA 221 and 222 levels are associated with aggressive prostate cancer.
  • Further investigation is required to validate ARHI and microRNAs 221/222 as predictive biomarkers for prostate cancer progression.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...